Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
55
SAN Quote, Financials, Valuation and Earnings
Last price:
$4.50
Seasonality move
:
1.11%
Day range:
$4.48 - $4.56
52-week range:
$3.83 - $5.27
Dividend yield:
4.66%
P/E ratio:
5.62x
P/S ratio:
1.12x
P/B ratio:
0.63x
Volume:
5.2M
Avg. volume:
3M
1-year change:
11.36%
Market cap:
$68.3B
Revenue:
$64.8B
EPS (TTM):
$0.80
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $57.2B | $53.4B | $57.3B | $57.2B | $64.8B | |
| Revenue Growth (YoY) | -2.56% | -6.59% | 7.26% | -0.17% | 13.38% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $22.1B | $20.3B | $21.4B | $21.5B | $23.5B | |
| Other Inc / (Exp) | $2.6B | $1.3B | $1.1B | $1.4B | $553.2M | |
| Operating Expenses | $24.8B | $11.5B | $24.4B | $24.4B | $26.7B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $14B | -$2.4B | $17.2B | $16.1B | $17.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5B | $6.4B | $5.8B | $4.7B | $4.6B | |
| Net Income to Company | $9.1B | -$8.8B | $11.4B | $11.4B | $13.2B | |
| Minority Interest in Earnings | -$1.8B | -$1.2B | -$1.8B | -$1.2B | -$1.2B | |
| Net Income to Common Excl Extra Items | $7.3B | -$10B | $9.6B | $10.1B | $12B | |
| Basic EPS (Cont. Ops) | $0.39 | -$0.61 | $0.52 | $0.57 | $0.71 | |
| Diluted EPS (Cont. Ops) | $0.39 | -$0.61 | $0.52 | $0.57 | $0.70 | |
| Weighted Average Basic Share | $16.3B | $17.3B | $17.3B | $16.8B | $16.2B | |
| Weighted Average Diluted Share | $17.1B | $17.3B | $17.3B | $16.9B | $16.2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $38.1B | $13.3B | $32.7B | $50.7B | $84.9B | |
| Revenue (Reported) | $57.2B | $53.4B | $57.3B | $57.2B | $64.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $38.1B | $13.3B | $32.7B | $50.7B | $84.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $13.3B | $14.4B | $13.4B | $16B | $16.4B | |
| Revenue Growth (YoY) | -3.51% | 7.82% | -7.02% | 19.55% | 2.7% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4B | $5.2B | $5.1B | $5.8B | $5.7B | |
| Other Inc / (Exp) | $504M | $283M | $374.7M | $726.2M | $589.5M | |
| Operating Expenses | $4.9B | $6B | $5.8B | $6.7B | $6.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.7B | $4.5B | $3.9B | $4.8B | $5.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3B | $1.5B | $1.2B | $1.4B | $1.5B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$347.3M | -$444.5M | -$261.9M | -$298.3M | -$372.8M | |
| Net Income to Common Excl Extra Items | $2B | $2.6B | $2.4B | $3.2B | $3.6B | |
| Basic EPS (Cont. Ops) | $0.11 | $0.13 | $0.14 | $0.19 | $0.22 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.13 | $0.14 | $0.19 | $0.22 | |
| Weighted Average Basic Share | $14.7B | $19.9B | $17.7B | $17.1B | $16.3B | |
| Weighted Average Diluted Share | $14.7B | $19.9B | $17.7B | $17.1B | $16.3B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $7B | $8.3B | $3.9B | $4.8B | $5.4B | |
| Revenue (Reported) | $13.3B | $14.4B | $13.4B | $16B | $16.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $7B | $8.3B | $3.9B | $4.8B | $5.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $53.8B | $57.1B | $55.2B | $60.7B | $66.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $20.6B | $21.3B | $21.3B | $22.3B | $23B | |
| Other Inc / (Exp) | $1.6B | $1.2B | $1.4B | $1.6B | $2.3B | |
| Operating Expenses | $13.6B | $23.3B | $25.1B | $25.3B | $25.7B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $857.7M | $14.2B | $16.9B | $17.2B | $19.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.4B | $5.2B | $5.1B | $4.8B | $5.4B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$1.3B | -$1.7B | -$1.4B | -$1.2B | -$1.2B | |
| Net Income to Common Excl Extra Items | -$6.8B | $7.3B | $10.4B | $11.2B | $13.3B | |
| Basic EPS (Cont. Ops) | -$0.43 | $0.39 | $0.58 | $0.65 | $0.81 | |
| Diluted EPS (Cont. Ops) | -$0.43 | $0.39 | $0.58 | $0.65 | $0.80 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $19.1B | $28.1B | $27.4B | $31.7B | $38.7B | |
| Revenue (Reported) | $53.8B | $57.1B | $55.2B | $60.7B | $66.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $19.1B | $28.1B | $27.4B | $31.7B | $38.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $39.3B | $43.1B | $41B | $47.1B | $51B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $14.3B | $15.3B | $15.3B | $16.9B | $17.2B | |
| Other Inc / (Exp) | $1.1B | $1B | $1.3B | $1.1B | $1.6B | |
| Operating Expenses | $5.3B | $16.8B | $17.6B | $19.3B | $19B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$3.4B | $12.8B | $12.5B | $13.6B | $15.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.6B | $4.5B | $3.8B | $3.9B | $4.6B | |
| Net Income to Company | -$11.4B | $5.4B | -- | -- | -- | |
| Minority Interest in Earnings | -$854.6M | -$1.4B | -$969.6M | -$912.9M | -$949.2M | |
| Net Income to Common Excl Extra Items | -$9.8B | $7B | $7.8B | $8.8B | $10.1B | |
| Basic EPS (Cont. Ops) | -$0.60 | $0.37 | $0.43 | $0.52 | $0.62 | |
| Diluted EPS (Cont. Ops) | -$0.60 | $0.37 | $0.43 | $0.52 | $0.62 | |
| Weighted Average Basic Share | $49.4B | $56.6B | $53.8B | $50.9B | $49.1B | |
| Weighted Average Diluted Share | $50.1B | $56.6B | $53.9B | $50.9B | $49.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $9.1B | $23.5B | $18.3B | $28.1B | $34.4B | |
| Revenue (Reported) | $39.3B | $43.1B | $41B | $47.1B | $51B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $9.1B | $23.5B | $18.3B | $28.1B | $34.4B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $143.9B | $212.8B | $265.9B | $265.1B | $272.9B | |
| Short Term Investments | $135.8B | $22B | $33.1B | $25.2B | $23.8B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $3.5B | $3.5B | $3B | $3.2B | $3.2B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $415.1B | $378.4B | $403.8B | $421.9B | $440.7B | |
| Property Plant And Equipment | $38.4B | $39.1B | $36.6B | $35.4B | $36.4B | |
| Long-Term Investments | $237.5B | $245.8B | $218.5B | $232.8B | $300.4B | |
| Goodwill | $27.2B | $15.3B | $14.4B | $14.7B | $15.5B | |
| Other Intangibles | $3.9B | $4.2B | $4.4B | $5.3B | $6.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.7T | $1.9T | $1.8T | $1.9T | $2T | |
| Accounts Payable | $2.1B | $2.5B | $2.7B | $3.2B | $3.7B | |
| Accrued Expenses | $7.7B | $7.8B | $8B | $9.1B | $10.1B | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $858.1M | $730.6M | $781.2M | $758.2M | $647.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $103.5B | $95B | $87.4B | $129.5B | $222.6B | |
| Long-Term Debt | $293.5B | $289.4B | $278.7B | $300.6B | $290.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.6T | $1.7T | $1.7T | $1.8T | $1.9T | |
| Common Stock | $9.3B | $10.7B | $9.8B | $9B | $8.9B | |
| Other Common Equity Adj | -$11.5B | -$8.5B | -$11.7B | -$17.2B | -$18.6B | |
| Common Equity | $112.1B | $100.2B | $98.4B | $95.6B | $105.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $11.9B | $12.1B | $11.5B | $9.1B | $9.7B | |
| Total Equity | $124B | $112.3B | $109.9B | $104.7B | $115.2B | |
| Total Liabilities and Equity | $1.7T | $1.9T | $1.8T | $1.9T | $2T | |
| Cash and Short Terms | $279.7B | $234.9B | $298.9B | $290.4B | $296.7B | |
| Total Debt | $293.5B | $289.4B | $278.7B | $300.6B | $341.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $210.2B | $319.2B | $342.9B | $361.9B | $326.1B | |
| Short Term Investments | $127.6B | $116.8B | $78.8B | $82.6B | $79.1B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $449.9B | $515B | $517.6B | $533.2B | $484.5B | |
| Property Plant And Equipment | $38B | $36.6B | $34B | $35.3B | $35.3B | |
| Long-Term Investments | $225.3B | $226.4B | $207.5B | $279.3B | $322.5B | |
| Goodwill | $14.5B | $14.7B | $13.9B | $14.9B | $15.1B | |
| Other Intangibles | $3.9B | $4.2B | $4.6B | $5.9B | $6.2B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.8T | $1.8T | $1.8T | $1.9T | $2T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.9B | $2.6B | $3.3B | $4.4B | $3.4B | |
| Long-Term Debt | $287.1B | $283.3B | $280.2B | $318.9B | $359.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7T | $1.7T | $1.7T | $1.8T | $1.9T | |
| Common Stock | $9.8B | $10.1B | $8.3B | $8.6B | $8.7B | |
| Other Common Equity Adj | -$44.5B | -$44.3B | -$37.8B | -$43.8B | -$50.1B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $11.2B | $11.9B | $8.1B | $9.2B | $9.5B | |
| Total Equity | $107.2B | $110.9B | $97.6B | $108.9B | $117.3B | |
| Total Liabilities and Equity | $1.8T | $1.8T | $1.8T | $1.9T | $2T | |
| Cash and Short Terms | $337.7B | $436B | $421.7B | $444.5B | $405.1B | |
| Total Debt | $287.1B | $283.3B | $280.2B | $318.9B | $359.6B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.1B | -$8.8B | $11.4B | $11.4B | $13.2B | |
| Depreciation & Amoritzation | $3.4B | $3.2B | $3.3B | $3.1B | $3.4B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.8B | $75.5B | $67.1B | $29.2B | $5.4B | |
| Capital Expenditures | $15.8B | $9.7B | $13.5B | $11.4B | $14.8B | |
| Cash Acquisitions | $151.1M | -$1.3B | -$158.5M | -$52.7M | -$421.1M | |
| Cash From Investing | -$8.1B | -$8.2B | -$4.4B | -$4.1B | -$5.8B | |
| Dividends Paid (Ex Special Dividend) | -$4.2B | -- | -$1.6B | -$1.9B | -$2.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $4.7B | $6.3B | $125.5M | $7.6B | |
| Long-Term Debt Repaid | -$5.7B | -$4.3B | -$3.2B | -$2.4B | -$3.2B | |
| Repurchase of Common Stock | -$1B | -$865.7M | -$1.9B | -$2.2B | -$3.4B | |
| Other Financing Activities | -$2.6B | -$2.5B | -$2.2B | -$4.7B | -$1.7B | |
| Cash From Financing | -$11.3B | -$2.2B | -$1.6B | -$10.5B | -$2.2B | |
| Beginning Cash (CF) | $127.2B | $115.4B | $182B | $222.2B | $241.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$15.6B | $65.1B | $61.1B | $14.6B | -$2.6B | |
| Ending Cash (CF) | $113.1B | $175.7B | $249.3B | $235.3B | $238.5B | |
| Levered Free Cash Flow | -$12B | $65.8B | $53.6B | $17.8B | -$9.3B | |
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.4B | $2.4B | $2B | -$12.1B | $3B | |
| Depreciation & Amoritzation | $753.7M | $700.1M | $810.7M | $758.3M | $841.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $14.4B | $14.5B | $8.9B | $20.4B | -$10.7B | |
| Capital Expenditures | $2.8B | $3.6B | $2.3B | $1.3B | $2.3B | |
| Cash Acquisitions | -$7.7M | $514.6M | $16.7M | $110.4M | -$62.7M | |
| Cash From Investing | -$1.2B | -$1.4B | -$2.3B | -$839M | -$587.1M | |
| Dividends Paid (Ex Special Dividend) | -$910.5M | -$1.1B | -$1.2B | -- | -$574.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $861.9M | $188.2M | -$13.2M | $385.4M | $1.9B | |
| Long-Term Debt Repaid | -$212.2M | -$1.1B | -$1.9B | -$355.1M | -$308.6M | |
| Repurchase of Common Stock | -$416.9M | -$257.4M | -$226.3M | -$154.6M | -$235M | |
| Other Financing Activities | $216.6M | -$418.2M | -$804.6M | -$544.9M | -$611.1M | |
| Cash From Financing | -$16M | -$2.4B | -$3.9B | -$505.7M | $398.8M | |
| Beginning Cash (CF) | $79.7B | $123.7B | $117.6B | $135.1B | $232.5B | |
| Foreign Exchange Rate Adjustment | -$3.5B | -$1.9B | -$1.8B | -$1.7B | -$963.5M | |
| Additions / Reductions | $13.3B | $10.6B | $2.7B | $19.1B | -$10.9B | |
| Ending Cash (CF) | $92.1B | $128.6B | $117B | $152.3B | $220.7B | |
| Levered Free Cash Flow | $11.6B | $10.8B | $6.5B | $19.1B | -$13B | |
| Period Ending | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.9B | $10.6B | -- | -- | -- | |
| Depreciation & Amoritzation | $3B | $3B | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $23.6B | $16.2B | -- | $90.8B | -- | |
| Capital Expenditures | $11B | $14.2B | $4.5B | $3.8B | $2.3B | |
| Cash Acquisitions | -$416.8M | -$339.4M | -$671.9M | $106.8M | -$62.7M | |
| Cash From Investing | $5.7B | -$5B | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$3.4B | -$3.7B | -$1.2B | -- | -$574.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5.7B | $1.7B | -- | -- | -- | |
| Long-Term Debt Repaid | -$2.5B | -$5.2B | -- | -- | -- | |
| Repurchase of Common Stock | -$1.5B | -$1.1B | -- | -- | -- | |
| Other Financing Activities | -$1.4B | -$1.4B | -- | -- | -- | |
| Cash From Financing | $6.4B | -$8.6B | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $35.7B | $2.7B | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $12.6B | $2.1B | $19.5B | $94.7B | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get SAN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SAN
Sector
P/E ratio
5.62x
11.99x
PEG ratio
0.25x
0.36x
P/B ratio
0.63x
1.05x
Price / LTM sales
1.12x
2.55x
Growth Metrics
SAN
Sector
Revenue growth
2.7%
6.08%
Earnings growth
18.84%
6.45%
Revenue (5-year growth)
2.02%
5.85%
Earnings forecast
$0.22
$0.56
Profitability
SAN
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
2.94%
5.27%
Return on assets
0.68%
0.98%
Return on equity
11.74%
9.43%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Jan
28
Balance Sheet
SAN
Sector
Total cash
$405.1B
$615.3M
Short term investments
$23.8B
$408.4M
Total assets
$2T
$4.5B
Long term debt
$359.6B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
